Characterization of the discriminative stimulus properties of centrally administered (-)-DOM and LSD

Pharmacology Biochemistry and Behavior

Volumn 74, Issue 3, 2003, Pages 713-721

  Doat, Mireille M ^a   Rabin, Richard A ^a   Winter, Jerrold C ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

2,5 Dimethoxy 4 methyl amphetamine (( ) DOM); Discriminative stimulus; Hallucinogen; Intracerebral injection; Intracerebroventricular; Lysergic acid diethylamide (LSD); Microinjection; Pirenperone

Indexed keywords

2,5 DIMETHOXY 4 METHYLAMPHETAMINE; LYSERGIDE; PSYCHEDELIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; BRAIN VENTRICLE; CANNULATION; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG POTENCY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0037304410     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(02)01074-2     Document Type: Article

References (36)

1. Axelrod J., Inscoe J.K. The uptake and binding of circulating serotonin and the effects of drugs. J. Pharmacol. Exp. Ther. 141:1963;161-165.
2. Brauer L.H., Goudie A.J., deWit H. Dopamine ligands and the stimulus effects of amphetamine: animal models versus human laboratory data. Psychopharmacology. 130:1997;2-13.
3. Browne R.B., Ho B.T. Role of 5-hydroxytryptamine in the discriminative stimulus properties of mescaline. Pharmacol. Biochem. Behav. 3:1975;429-435.
4. Easterling K.W., Holtzman S.G. Comparison of the discriminative and antinociceptive effects of morphine and its glucuronide metabolites after central or systemic administration in the rat. Psychopharmacology. 140:1998;91-97.
5. Eckler J.R., Greizerstein H., Rabin R.A., Winter J.C. A sensitive method for determining levels of [-]-2,5,-dimethoxy-4-methylamphetamine in brain tissue. J. Pharmacol. Toxicol. Methods. 36:2001;37-43.
6. Fiorella D., Palumbo P.A., Rabin R.A., Winter J.C. The time-dependent stimulus effects of R(-)-2,5-dimethoxy-4-methamphetamine ((-)-DOM): implications for drug-induced stimulus control as a method for the study of hallucinogenic agents. Psychopharmacology. 119(2):1995;239-245.
7. 2C receptors in the stimulus effects of effects hallucinogenic drugs: I. Antagonist correlation analysis. Psychopharmacology. 121:1995;347-356.
8. Glennon R.A., Rosecrans J.A., Young R. Drug-induced discrimination: a description of the paradigm and a review of its specific application to the study of hallucinogenic agents. Med. Res. Rev. 3:1983;289-340.
9. 2 antagonists. Eur. J. Pharmacol. 91:1983;189-196.
10. Hirschhorn I.D., Winter J.C. Mescaline and lysergic acid diethylamide (LSD) as discriminative stimuli. Psychopharmacology. 22:1971;64-71.
11. Hodge C.W. Comparison of the discriminative stimulus function of ethanol following intracranial and systemic administration: evidence of a central mechanism. Pharmacol. Biochem. Behav. 47:1994;743-747.
12. Hollister L.E., MacNicol M.F., Gillespie H.K. An hallucinogenic amphetamine analog ((-)-DOM) in man. Psychopharmacology. 14:1969;62-73.
13. Keenan K.P., Smith P.F., Hertzog P., Soper K., Ballam G.C., Clark R.L. The effects of overfeeding and dietary restriction on Sprague-Dawley rat survival and early pathology biomarkers of aging. Toxicol. Pathol. 22:1994;300-315.
14. Kulig K. Emergency aspects of drug abuse: LSD. Emerg. Med. Clin. North Am. 3:1990;551-558.
15. Locke K.W., Holtzman S.G. Characterization of the discriminative stimulus effects of centrally administered morphine in the rat. Psychopharmacology. 87:1985;1-6.
16. Minnema D., Krynock G., Young R., Glennon R., Rosecran J. LSD as a discriminative stimulus: role of the dorsal raphe nucleus. Subst. Alcohol Actions/Misuse. 1:1980;29-34.
17. Mockler D.J., Rech R.H. Behavioral effects of intracerebroventricular administration of LSD, (-)-DOM, mescaline or lisuride. Pharmacol. Biochem. Behav. 21:1984;281-287.
18. Mockler D.J., Stoudt Katherine W., Sherman L.C., Rech R.H. The effects of intracranial administration of hallucinogens on operant behavior in the rat: I. Lysergic acid diethylamide. Pharmacol. Biochem. Behav. 25:1986;717-735.
19. Mockler D.J., Stoudt Katherine W., Sherman L.C., Rech R.H. The effects of intracranial administration of hallucinogens on operant behavior in the rat: II. 2,5-Dimethoxy-4-methylamphetamine ((-)-DOM). Pharmacol. Biochem. Behav. 28:1986;327-334.
20. Nichols D.E., Shulgin A.T., Dyer D.C. Directional lipophilic character in a series of psychotomimetic phenethylamine derivatives. Life Sci. 21:1977;569-576.
21. Nielsen E.B., Scheel-Kruger J. Cueing effects of amphetamine and LSD: elicitation by direct microinjection of the drugs into the nucleus accumbens. Eur. J. Pharmacol. 125:1986;85-92.
22. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 2nd ed. 1986;Academic Press, New York.
23. Sanger D.J., Benavides J., Perrault G., Morel E., Cohen C., Joly D.et al. Recent developments in the behavioral pharmacology of benzodiazepine [omega] receptors: evidence for functional significance of receptor subtypes. Neurosci. Biobehav. Rev. 18:1994;355-372.
24. Sannerud C.A., Ator N.A., Griffiths R.R. Comparison of the discriminative stimulus effects of midazolam after intracranial and peripheral administration in the rat. Life Sci. 49:1991;261-268.
25. Schecter M.D., Schechter J.B., Calcagnetti D.J. Direct microinjection of cathinone into the rat brain produces discriminative stimuli. Pharmacol. Biochem. Behav. 42:1992;619-623.
26. Schuster C., Johanson C. Relationship between the discriminative stimulus properties and subjective effects of drugs. Colpaert F., Balster R. Transduction mechanisms of drug stimuli. 1988;161-175 Springer, Berlin.
27. Severs W.B., Summy-Long J. The role of angiotensin in thirst. Life Sci. 17:1976;1513-1526.
28. Shoaib M., Stolerman I.P. Brain sites mediating the discriminative stimulus effects of nicotine in rats. Behav. Brain Res. 78:1996;183-188.
29. Shulgin A., Shulgin A. PIHKAL: a chemical love story. 1991;453-924 Transform Press, Berkley.
30. Silverman P.B., Ho B.T. The discriminative stimulus properties of 2,5-dimethoxy-4-methylamphetamine [DOM]: differentiation from amphetamine. Psychopharmacology. 68:1980;209-215.
31. 2A receptors in the ventral pallidum. Brain Res. 761:1997;97-104.
32. Slifer B.L., Balster R.L. A comparison of the discriminative stimulus properties of phencyclidine, given intraperitoneally or intraventricularly in rats. Neuropharmacology. 24:1985;1175-1179.
33. Snyder S.A., Faillace L., Hollister L. 2,5-Dimethoxy-4-methylamphetamine [R(-)(-)-DOM] and S-amphetamine in the rat. Psychopharmacology. 44:1968;229-239.
34. White F.J., Appel J.B. Training dose as a factor in LSD-saline discrimination. Psychopharmacology. 76:1982;20-25.
35. Winter J.C. Behavioral effects of N,N-diethyltryptamine: absence of antagonism by xylamidine tosylate. J. Pharmacol. Exp. Ther. 169:1969;7-16.
36. Winter J.C. Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide: the role of 5-Hydroxytryptamine. J. Pharmacol. Exp. Ther. 204:1978;416-423.